What difference could new Alzheimer’s disease...

We’ve had two heatwaves already this summer with warnings that even young and healthy people should rethink their fitness routines in the heat. So how can we keep exercising when it’s so hot you barely want to move? James chats with physiologist Damian Bailey from the University ...  Show more

Earlier this summer, there was some incredible progress in cervical cancer. Women who have been vaccinated against the human papillomavirus (HPV) now have an almost zero chance of dying from cervical cancer before the age of 30. But does that mean women will no longer need cervic ...  Show more

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  Show more

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ...  Show more

For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled the country meeting people who have slowed, prevented, and in some cases even reversed the spread of Alzheimer’s ...  Show more